1-3 of 3
John Adams
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors

Mariam Alatrach, Nitchakarn Laichuthai, Robert Martinez, Christina Agyin, Ali Muhammed Ali, Hussein Al-Jobori, Olga Lavynenko, John Adams, Curtis Triplitt, Ralph DeFronzo, Eugenio Cersosimo, Muhammad Abdul-Ghani
Journal: Diabetes
Diabetes 2020;69(4):681–688
https://doi.org/10.2337/db19-0770
Published: 08 January 2020
View article titled, Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors
Open the PDF for Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors in another window
Includes: Supplementary data
Journal Articles

Endogenous Glucose Production and Hormonal Changes in Response to Canagliflozin and Liraglutide Combination Therapy

Robert Martinez, Hussein Al-Jobori, Ali M. Ali, John Adams, Muhammad Abdul-Ghani, Curtis Triplitt, Ralph A. DeFronzo, Eugenio Cersosimo
Journal: Diabetes
Diabetes 2018;67(6):1182–1189
https://doi.org/10.2337/db17-1278
Published: 30 March 2018
View article titled, Endogenous Glucose Production and Hormonal Changes in Response to Canagliflozin and Liraglutide Combination Therapy
Open the PDF for Endogenous Glucose Production and Hormonal Changes in Response to Canagliflozin and Liraglutide Combination Therapy in another window
Journal Articles

Inhibition of Renal Sodium–Glucose Cotransport With Empagliflozin Lowers Fasting Plasma Glucose and Improves β-Cell Function in Subjects With Impaired Fasting Glucose

Muhammad Abdul-Ghani, Hussein Al Jobori, Giuseppe Daniele, John Adams, Eugenio Cersosimo, Curtis Triplitt, Ralph A. DeFronzo
Journal: Diabetes
Diabetes 2017;66(9):2495–2502
https://doi.org/10.2337/db17-0055
Published: 13 June 2017
View article titled, Inhibition of Renal Sodium–Glucose Cotransport With Empagliflozin Lowers Fasting Plasma Glucose and Improves β-Cell Function in Subjects With Impaired Fasting Glucose
Open the PDF for Inhibition of Renal Sodium–Glucose Cotransport With Empagliflozin Lowers Fasting Plasma Glucose and Improves β-Cell Function in Subjects With Impaired Fasting Glucose in another window